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ARTICLE
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heterogeneous clonal contribution to mouse
pancreas organogenesis
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Spatiotemporal balancing of cellular proliferation and differentiation is crucial for postnatal
tissue homoeostasis and organogenesis. During embryonic development, pancreatic
progenitors simultaneously proliferate and differentiate into the endocrine, ductal and acinar
lineages. Using in vivo clonal analysis in the founder population of the pancreas here we
reveal highly heterogeneous contribution of single progenitors to organ formation. While
some progenitors are bona ﬁde multipotent and contribute progeny to all major pancreatic
cell lineages, we also identify numerous unipotent endocrine and ducto-endocrine bipotent
clones. Single-cell transcriptional proﬁling at E9.5 reveals that endocrine-committed cells are
molecularly distinct, whereas multipotent and bipotent progenitors do not exhibit different
expression proﬁles. Clone size and composition support a probabilistic model of cell fate
allocation and in silico simulations predict a transient wave of acinar differentiation around
E11.5, while endocrine differentiation is proportionally decreased. Increased proliferative
capacity of outer progenitors is further proposed to impact clonal expansion.
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Deﬁning the rules governing embryonic organ developmentand postnatal tissue homoeostasis is essential for under-standing disease pathology and for the generation of
functional cell types for regenerative medicine purposes. Seminal
studies have demonstrated how rapidly proliferating postnatal
tissues such as the skin and the intestine are homeostatically
maintained by equipotent stem cells undergoing seemingly
stochastic cell fates choices by neutral competition for limited
niche signals1–4. In contrast to postnatal tissue homoeostasis,
embryonic development of most organs occurs at a state of
system disequilibrium, as a population of progenitors expands
while simultaneously giving rise to differentiating progeny.
Although optimality in the design of strategies ensuring rapid
organ development has been proposed5, little is known regarding
how global embryonic organogenesis is orchestrated when
deconstructed into clonal units originating from single progeni-
tors at the onset of organ bud formation. Studies of retinal
development have provided compelling evidence for a stochastic
process of cell fate choices using both in vitro6 and in vivo
approaches7. However, a deterministic model of embryonic
neocortical development was proposed8, based on the observation
of similar behaviour of the two daughters of individual cells.
These discrepancies in organ design emphasise the need for
studies investigating individual cell progenies in other organ
systems. Here we investigate how the allocation of endocrine and
acinar fates is balanced with progenitor expansion from the
beginning of pancreas formation using clonal analysis and single-
cell molecular proﬁling.
Embryonic mouse pancreas development is initiated at around
embryonic day (E)9.0 by the speciﬁcation of pancreatic
progenitors at the dorsal and ventral sides of the posterior foregut
endoderm9. Though induced by different mechanisms, the two
anlage are composed of expanding Pdx1+Hnf1b+Sox9+Ptf1a+
progenitors forming bud-like structures protruding into the sur-
rounding mesenchyme10. A small number of Neurog3+ endocrine
precursors giving rise to the endocrine lineage of the pancreas are
also found in these early buds11, 12. Morphogenetic processes
occur concomitantly leading to the formation of lumens and their
organisation into a plexus and subsequent tree-like branches13, 14.
While the distal tip-domain is comprised of Ptf1a+ unipotent
acinar progenitors after E13.515, 16, the Hnf1b+ trunk domain is
bipotent and gives rise to endocrine cells, as well as the ductal
cells that will eventually line the epithelial network draining
acinar digestive enzymes to the duodenum17–19. Following
speciﬁcation towards the endocrine lineage, Neurog3+ endocrine
precursors delaminate from the epithelial trunk domain to form
immature islet clusters that will eventually mature into the
endocrine Islets of Langerhans20. Although population-based
lineage tracing has demonstrated the multipotency of the early
pancreatic progenitors by virtue of their capability to give rise to
progeny in the three major pancreatic lineages12, 15–17, 21
(Fig. 1a), no study has addressed the clonal contribution of the
proposed multipotent pancreatic progenitors (MPCs) to pancreas
organogenesis. One previous clonal analysis indeed restricted its
focus on the progeny of single endocrine precursors examining
their postnatal expansion22. Recent studies have demonstrated
that pancreatic trunk progenitors undergo stochastic priming
towards the endocrine lineage at mid-gestation19, and thus we
questioned whether there are subpopulations of pancreatic
progenitors exhibiting restricted lineage potencies from the onset
of embryonic pancreas development or whether progeny from
equipotent progenitors undergo stochastic lineage commitment.
In this study, using clonal analysis of E9.5 pancreatic progeni-
tors, when the pancreatic primordium has just been speciﬁed, we
demonstrate that individual pancreatic progenitors contribute
heterogeneously to pancreas organogenesis both in progeny size
and fate composition. While some progenitors are multipotent
per se, giving rise to acinar, endocrine and ductal progeny, we
also demonstrate the existence of bipotent ducto-endocrine and
unipotent endocrine cells forming half of the primordium. This
population represents cells at different stages of progression on the
endocrine differentiation path, including proliferative endocrine-
committed cells, and exhibits undetectable to low levels of PTF1A.
In contrast, bipotent and multipotent clones do not exhibit dif-
ferent expression proﬁles, suggesting they are not molecularly
distinct cell populations. We show that clonal expansion and fate
heterogeneity are compatible with a simple model of probabilistic
cell fate acquisition operating downstream of spatially controlled
proliferative and fate-biasing patterning cues.
Results
Single E9.5 pancreatic cells produce heterogeneous progeny. To
investigate how individual cells among the about 500 cells that
have just been speciﬁed to found the pancreas contribute to
organogenesis, we devised a lineage tracing strategy making use of
the Rosa26CreER driver (Fig. 1b). The ubiquitous activity of the
Rosa26 locus ensures CreER expression throughout the develop-
ing embryo and hence also enables non-biased labelling of
pancreatic cells23. We selected the mT/mG24 reporter over other
multicolour reporters to be able to mark the differentiation status
of clonal progeny. This required the dosage of very low levels of
the active tamoxifen metabolite 4-OH tamoxifen (4-OHTm) to
reach labelling of only one cell per pancreatic primordium within
the 24 h following injection25. The labelling index of 11.8%
(20 epithelial clones in 170 embryos) ensured a low risk of
labelling two progenitors in the same pancreatic bud as of 1.4%
(0.118×0.118). Whole-mount staining of E14.5 pancreata
for endocrine (PAX6), progenitors lining the ducts (SOX9) and
acinar (CPA1) markers enabled us to determine the fate of
labelled GFP+ progeny at E14.5, a stage by which acinar cells are
committed (Fig. 1c–h)12, 15–17. We observed a large extent of
clone size heterogeneity, ranging from single-cell clones to clones
consisting of hundreds of cells (Fig. 1h). Single GFP+ cells
belonged to the endocrine lineage based on immunoreactivity
for PAX6, cell morphology and location outside the pancreatic
epithelium in islet-like structures (Fig. 1d, f, g). These single cells
are expected to result from labelling non-proliferative endocrine
cells, their Neurog3-expressing precursors or pancreatic pro-
genitors differentiating directly into the endocrine lineage without
dividing. We also observed 2- and 3-cell endocrine clones, sug-
gesting that a labelled endocrine-biased progenitor had under-
gone a single or two rounds of divisions. In line with the
postulated existence of multipotent progenitors based on non-
clonal analyses, multipotent clones of 40–250 cells were found,
consisting of ductal, endocrine and acinar progeny (Fig. 1h).
Moreover we did observe bipotent clones of 6–100 cells
harbouring only ductal and endocrine progeny, indicating that
not all E9.5 progenitors contribute to the acinar lineage during
pancreas organogenesis. However, we did not observe unipotent
acinar clones arising from E9.5 progenitors. While conﬁrming the
existence of MPCs at the single-cell level, our results reveal
heterogeneity in potency and contribution to pancreas organo-
genesis from single pancreatic cells. Furthermore they uncover
the existence of bipotent progenitors as early as E9.5 and that half
of the cells in the early pancreatic anlage give rise to solely
endocrine progeny, a surprising ﬁnding considering that the adult
endocrine cells only account for about 1% of the adult organ26.
Heterogeneous marker expression in E9.5 progenitors.
Heterogeneity in the clonal progeny may be either due to an
intrinsic lineage bias in sub-populations of E9.5 progenitors or
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due to the stochastic fate allocation of clonal progeny during
progressive organisation and compartmentalisation of the
pancreatic epithelium. To test the ﬁrst hypothesis, we conducted
single-cell qRT-PCR following FACS isolation of dorsal foregut
progenitor cells at E9.5 (Fig. 2a). tSNE-mediated dimensionality
reduction of single cells revealed the existence of three distinct
populations (Fig. 2b). On the basis of the expression of known
lineage markers, we classify these three clusters as pancreatic
endocrine (Neurog3+ and Glucagon+), pancreatic progenitors
(Pdx1+ and Sox9+) and duodenal progenitors (Cdx2+, absence of
Pdx1 and Sox9). Interestingly, cells characterised as belonging to
the endocrine lineage organised on one projection axis forming a
pseudo-temporal trajectory starting from Neurog3+ endocrine
precursors and progressing with the expression of markers
associated with progressive endocrine maturation (Fig. 2c).
These molecularly distinct cells are expected to contribute to the
non-proliferative endocrine-committed cells observed in the
lineage tracing. When focusing the dimensionality reduction
on Pdx1+ pancreatic progenitors only, we observed marked
heterogeneities in expression of various pancreas-associated
transcription factors. Since at E14.5 Ptf1a marks acinar cells at
the tip while Nkx6-116, 27, Hnf1b17 and Hes118 mark bipotent
progenitors in the trunk, we investigated whether cells expressing
these markers at E9.5 already had speciﬁc molecular signatures
suggestive of emerging tip and trunk fates. However, in spite of
heterogeneous expression of these markers, no global gene
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Fig. 1 Rosa26CreER-mediated clonal analysis reveals heterogeneous contribution of E9.5 progenitors to pancreas organogenesis. a Schematic overview
of lineage relationships based on previous global lineage tracing. b Schematic overview of strategy applied to identify fates of clonal progeny from
E9.5 pancreatic progenitors. c 3D maximum intensity projection (MIP) of a large, multipotent clone containing acinar (CPA1), progenitors lining the
ducts (SOX9) and endocrine progeny (PAX6, from other multipotent clone) d. Scale bars, 100 µm c and 15 µm d. e 3D MIP of a bipotent clone
containing endocrine (insets 1 and 2) and ductal (inset 3) clonal progeny f. Scale bars, 100 µm e and 10 µm f. g 3D MIP and optical section (inset)
showing a single-labelled endocrine cell after clonal analysis from E9.5 to E14.5. Note the localisation of the GFP+ cell in an E-CADLow endocrine cluster.
Scale bars, 80 µm and 15 µm (inset). h Quantiﬁcation of clone sizes and compositions following clonal analysis from E9.5 to E14.5 (n= 170 embryos,
20 with clones, 1 excluded due to poor immunocytochemistry-the images displayed show representative data from those)
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signature was associated with Nkx6-1, Hnf1b or Hes1, and these
three markers showed no cross-correlation (Fig. 2d, e; Supple-
mentary Figs. 1–4). Although Ptf1a expression did not correlate
strongly with speciﬁc single markers, Ptf1a+-cells clustered after
tSNE-mediated dimensionality reduction, suggesting that they are
more similar to each other than to other progenitor cells. This
molecular analysis uncovers that cells committed to endocrine
differentiation can be molecularly identiﬁed, whereas
subpopulations of multipotent or bipotent progenitors identiﬁed
by clonal analysis cannot be molecularly predicted with this set
of markers.
Spatial patterns of progenitor marker expression. To further
assess heterogeneity in markers at the protein level, we used
whole-mount immunostaining of E9.5 gut tubes and quantitative
image analysis (Fig. 3a, b). We observed heterogeneous expres-
sion levels of HES1, SOX9 and PTF1A, whereas HNF1B and
PDX1 were more homogeneously expressed among progenitors
(Fig. 3c, d). Using 3D Voronoi-Delaunay triangulation (Fig. 3a)
and measurements of the correlation in expression levels between
neighbouring cells, we observed that HNF1B is expressed at
higher levels towards the more posterior side of the pancreatic
bud and in the gut tube and that PTF1A expressing cells appear
clustered at a medial-bilateral location in E9.5 dorsal buds. Other
transcription factors did not show any regionalisation
of expression levels (Fig. 3d). These results demonstrate that
the transcriptional proﬁles observed by single-cell qRT-PCR
are translated into similar global proﬁles at the protein level, and
that the levels of PTF1A and HNF1B display regionalised patterns
in the E9.5 bud.
Distinct clonal progeny of Hnf1b- and Ptf1a-expressing cells.
The differential expression of PTF1A and HNF1B at E9.5 and
the subsequent segregation of these markers to the tip and
trunk domain, respectively, led us to investigate whether
single progenitors expressing Ptf1a or Hnf1b at E9.5 contribute
differential progeny by clonal analysis using Ptf1aCreER- and
Hnf1bCreER drivers (Fig. 4a). The Hnf1bCreER-driver (labelling
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Fig. 2 Single-cell qRT-PCR of E9.5 pancreatic progenitors reveals endocrine differentiation progression but no apparent tip-trunk segregation signature.
a Schematic outline of the strategy used to isolate single pancreatic progenitor cells for single-cell qRT-PCR analysis using the Hes1-eGFP strain43.
b tSNE dimensionality reduction of all single cells passing initial quality controls. Three cell clusters are displayed in green, black and red, corresponding
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population cluster organise on a pseudo-temporal differentiation pathway starting with Neurog3+ endocrine precursors at the left, progressing
into glucagon-expressing terminally differentiated endocrine cells at the right. d tSNE dimensionality reduction of Pdx1+ pancreatic progenitors only.
e Despite heterogeneous expression of transcription factors and signalling components involved in subsequent tip-trunk segregation, expression
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index: 35 clones in 120 pancreata, 29%; probability of double
labelling, 8%) resulted in a similar pattern of clones as observed
with Rosa26CreER, that is unipotent endocrine, bipotent ducto-
endocrine as well as multipotent clones (Fig. 4b, c and f).
However, the endocrine-committed clones were less frequent,
constituting 33% instead of 50% of the total clone repertoire,
likely due to the fact that unlike Rosa26, Hnf1b is not expressed in
mature endocrine cells28. In addition, we detect HNF1B
immunoreactivity in 67.7± 3.8% of the NEUROG3-expressing
endocrine precursors at this stage, while Rosa26 is expected to
be expressed in all (Supplementary Fig. 5). A similar frequency
of endocrine-committed precursors was observed when
tracing Hnf1bCreER-labelled cells from E9.5 to E10.5 (Supple-
mentary Fig. 6). Interestingly, we observed a clone consisting
solely of 6 endocrine cells. Combined with the two 3-cell clones
seen in the Rosa26 tracing, this suggests that some endocrine-
biased progenitors can undergo multiple rounds of divisions
(Fig. 4b, f; clone # 12), in line with the recent observation that
cells with low levels of Neurog3 transcription can proliferate29.
The low-differentiation rate towards the endocrine lineage
(p= 0.12± 0.007, Supplementary Fig. 7) makes independent
probabilistic entry of progeny into the endocrine lineage highly
unlikely, suggesting that the E9.5 pancreatic bud contains
progenitors biased towards multigenerational endocrine
speciﬁcation. On the other hand, we never observed unipotent
acinar clones arising from E9.5 progenitors. Furthermore, acinar-
containing clones always contained ductal and endocrine
progeny, suggesting that acinar-lineage allocation has not yet
occurred in any cell at E9.5. The proportion of multipotent clones
was similar to what was observed using the Rosa26CreER driver
after correction for the absence of labelling of mature endocrine
cells by Hnf1bCreER. Though only ﬁve of the clones were found in
the ventral pancreas, which is smaller than the dorsal, they were
bi- or multipotent but not endocrine committed, possibly due to a
delay in endocrine program onset in the ventral pancreas.
This suggests that the assumed labelling of progenitors with
high-expression levels of Hnf1b expression at E9.5 does not bias
lineage contribution to the trunk domain (Fig. 4f). Similarly,
Ptf1aCreER-based lineage tracing did not bias progenitors towards
the acinar lineage, either (Fig. 4d, e and g). However, cells traced
by Ptf1aCreER (labelling index: 13 clones in 30 dorsal pancreata,
44%; probability of double labelling, 19%) did not form
endocrine-only clones, unlike what was seen with Rosa26CreER-
and Hnf1bCreER-drivers. This suggests that cells exhibiting high
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Ptf1a expression at around E9.5 do not immediately form
endocrine cells, unlike progenitors traced by Rosa26CreER and
Hnf1bCreER, though they retain endocrine differentiation capacity
as these cells give rise to endocrine-containing clones later in
their clonal evolution. This hypothesis is supported by Ptf1a anti-
correlation with early markers of endocrine differentiation such
as Mfng and Neurog3 in our single-cell qRT-PCR analysis at E9.5
(Supplementary Fig. 3).
A probabilistic model of progenitor progeny fate allocation.
The apparent lack of tip-trunk biased progenitors suggested by
both single-cell analysis and tracing at E9.5 led us to investigate
whether a model of probabilistic cell-fate choices could recapi-
tulate the in vivo clonal distribution data. To this end, we con-
structed a mathematical model of in silico clonal growth by
simulating cell divisions over a period spanning the in vivo clonal
tracing. Every time a cell gave rise to progeny through cell
division, clonal progeny were fate-allocated with a probability of
a
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probability f and acinar (purple) with probability 1 − f. We compare two models: in Model 1 the probability f is constant between E9.5 and E14.5, and in
Model 2f is time-dependent and has a minmum at around E12. The height of the minimum is characterised by parameter q. In Model 1 f= g. See Methods
for the exact functional form of f for Model 2. While acinar cells continue replicating, endocrine cells are assumed not to replicate. For all replicating cells
the cell-cycle lengths are drawn from the gamma distribtuion from19 (right panel). For every parameter set both models were simulated 2500 times.
b Examples of the in silico clonal lineages. c Fraction of cell types from individual clones at E9.5, 11.5, 12.5 and 14.5 (corresponds to experimental data in
Supplementary Fig. 7d). d Clonal composition at E14.5 (corresponds to Figs. 1h and 4f). e For each of the parameter sets c, q we estimate the likelihood of
the model ﬁtting the data (See Methods and Supplementary Figs. 8–10). The results of the parameter scan are quantiﬁed by the log-likelihood, −2log(L).
Parameter scans show that Model 2, where the differention of acinar cells and endocrine cells change with time, is more likely. Using Akaike Information
Criteria score, AIC, we ﬁnd that Model 2 is better at describing the data (AIC1= −14.5 and AIC2= −22.1). The probability that the two models are equally
good is p= 0.02. f The model predicts that if clonal anlyses are started at E11.5–12 instead of E9.5, it becomes more likely to observe lineages fully
commiting to the acinar fate
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differentiating c and a probability of becoming endocrine cf or
acinar c(1 − f) (Fig. 5a). Here f is a bias towards endocrine fate; f
= 0.5means that cells are equally likely to be allocated exocrine or
endocrine fates. Simulated cell cycle lengths were randomly
drawn from a gamma-distribution based on our measurements
in vitro19 and those of Bankaitis et al.30 in vivo. Progeny
committed to the endocrine lineage were approximated to be
non-proliferative while acinar cells proliferated. For simplicity
the acinar proliferation rate was approximated to be similar to
progenitors, which is a small underestimation15. In total 2500
clones were simulated spanning a parameter space of probabilities
for both c and f (Fig. 5b, d). Two models were compared, one
with ﬁxed probability of becoming endocrine rather than exocrine
f= q, or one where f varied over time with a minimum q around
E12 (Fig. 5a). The minimum around E11.75-E12 is suggested by
the observation that the number of NEUROG3-expressing cells
has a minimum at this time point31.
To quantitatively compare simulation results with the data, we
focused on two types of datasets. First, histograms in Figs. 1h and 4f
contain information about the clonal variance in fractions of acinar
and endocrine cells at one time point E14.5. For simplicty we focused
on the variance in fractions of acinar cells and to increase sample size
combined the datasets in Figs. 1h and 4f into one. Second, the
staining of pancreata at four time points in Supplementary Fig. 7d
does not contain information about the clonal variance but
reperesents the typical cell fractions. To compare our models with
the ﬁrst data set we recorded the acinar fraction from simulated
lineages with at least one acinar cell for each parameter set
(Supplementary Fig. 8a–e). We estimated the underlying probability
density function (PDF), shown on top of the histogram in
Supplementary Fig. 8e by Kernel Density estimation with bandwidth
0.5 (see Supplementary Fig. 9 and methods for details).
To compare our models with the second data set, we grouped
together 100 clones to approximate the data from stained
pancreata in Supplementary Fig. 7d. Here we used both acinar
and endocrine fractions at E10.5, 11.5, 12.5 and 14.5 to estimate
PDFs as described above. This allowed us to estimate the
likelihood that the experimental data points came from the PDF
derived from the simulations. In other words we estimated how
likely it is for simulations to produce exactly those fractions
observed in vivo. The likelihood that both datasets agree with
the model was a product of each of the two likelihoods
(Methods, Model Implementation). Spanning a parameter space
for c and q (Supplementary Fig. 10), we observed that both the
model 1 with ﬁxed endocrine/acinar probability and the model 2
displaying temporal variations in this ratio had a parameter space
of good likelihood for c and q (Fig. 5e). However, the model 2
with a time-variable probability of becoming acinar peaking at
around E12 was superior at describing the data according to the
Akaike Information Criteria (AIC, see Methods). The shape of
the optimal parameter space is also in support of model 2:
once the probability to become acinar is set to peak around E12
(model 2), the performance of the model becomes less
constrained by parameter q. The statstical approach used allows
us to identify the best model, but a combination of limited
amount of biological data and high stochasticity prevents us from
statistically testing how well each model match the data. Taken
together, our mathematical modelling suggests that the clonal
analysis data are compatible with a model of probabilistic cell fate
choices and predicts that when the probability of becoming
endocrine is low at around E12, the progenitors most efﬁciently
commit to the acinar lineage at this time point.
Acinar-committed cells are detected from E11.5 to 12.
According to the model prediction, acinar-committed cells should
be undetectable at E9.5, as we have seen, but should be easily
identiﬁed by clonal lineage tracing from E11.5 (Fig. 5f). Previous
non-clonal tracing with Ptf1aCreER suggested that all cells
expressing Ptf1a were acinar-committed at E14.5–E15, whereas
some were still multipotent at earlier time points15. However,
previous observations did not address whether some cells may
be acinar-committed earlier. Tracing using Ptf1aCreER;mT/mG
mice injected with 4-OHTm at E11.5 revealed bipotent and
tripotent clones, as at earlier time points and also showed that 8%
of the PTF1A-traced cells were already acinar-committed (Fig. 6),
4-OHTm injection at E11.5 in mouse
carrying Ptf1aCreER;mT/mG embryos
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Fig. 6 Ptf1aCreER-mediated clonal analysis identiﬁes unipotent acinar progenitors at E11.5. a Schematic overview of strategy applied to identify fates of clonal
progeny from E11.5 pancreatic progenitors. b Quantiﬁcation of clone sizes and fate compositions following Ptf1aCreER-mediated clonal analysis (n= 24
clones in 70 embryos analysed). Arrows indicate two acinar unipotent acinar clones, as predicted by our mathematical model. c A representative 3D MIP
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pancreas. Scale bars, 20 µm
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reinforcing the notion of heterogeneity in progenitor behaviours
at the clonal level during pancreas organogenesis.
Spatial differences in proliferation impacts clonal growth. In
addition to the compatibility of the in vivo clonal heterogeneity
with a probabilistic model of cell cycle progression and cell fate
allocation, we questioned whether spatial patterns of differential
proliferation rates might also impact clone size. To interrogate
the proliferative capacity of pancreatic epithelial subdomains we
performed a label dilution experiment using Pdx1-tTA;tetO-H2B-
GFP embryos (Fig. 7a). These embryos display ubiquitous H2B-
GFP expression in Pdx1+ progenitors, however upon doxycycline
(Dox) administration, H2B-GFP expression is suppressed and
will be linearly diluted by equal partition to daughter cells upon
cell division32. By tracing the extent of label dilution from E9.5
to E12.5 and E14.5, we observed label retention in SOX9NegE-
CADLow cell clusters corresponding to non-proliferative endo-
crine cells derived early after suppression of H2B-GFP expression
(Fig. 7b, c). Label dilution following continuous Dox adminis-
tration from E9.5 was evident in SOX9+ progenitors compared to
endocrine cells at E12.5, and this was even more apparent at
E14.5 (Fig. 7b, c). At E14.5, cells located in the central portion
of the SOX9+ epithelium still displayed retention of H2B-GFP
signal, whereas SOX9+ progenitors in lateral branches and the
more distal portion of the epithelium displayed label dilution.
This was also apparent when administering Dox at E11.5 and
tracing to E14.5 (Fig. 7d). These results suggest that pancreatic
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SOX9+ ductal progenitors undergo preferential proliferation
at the peripheral epithelial domains. Such preferential label
retention within the central epithelial domain was additionally
conﬁrmed by plotting the 2D kernel density estimation of SOX9+
and GFP-retaining SOX9+ progenitors (Fig. 7e). To investigate
whether the size of clones from our lineage tracing correlated
with the spatial location of H2B-GFP retaining SOX9+ progeni-
tors, we sought to map the spatial location of clones onto
the domains of differential label retention. Because of the
non-stereotypic macroscopic anatomy of the pancreata between
embryos, we turned to a simplistic model of spatial mapping,
where we projected the location of a cell or group of cells on an
axis extending from the tip of the dorsal pancreas to the duodenal
root of the dorsal pancreas. This method conﬁrms the enrichment
of H2B-GFP-retaining SOX9+ cells in a central domain of the
pancreas epithelium at E14.5 (Fig. 7f) and indicates that the
largest Hnf1bCreER-derived clones tend to map to the tip
(Fig. 7g–i). These results suggest that the spatial location impacts
the proliferation of clonal progeny by dispersal to spatial niches
with distinct proliferative capacity.
Discussion
In this study we aimed at uncovering whether the roughly
500 cells that found the mouse pancreas contribute homo-
geneously to the size of the ﬁnal organ and to its different
functional cell types. The multipotent state of the early pancreatic
progenitor population has been inferred from population-based
lineage tracing studies, masking potential heterogeneity in single-
progenitor contribution to organ formation12, 15, 21. We tested
whether there are subpopulations with biases in proliferation or
differentiation capacity, and whether they can be predicted by
their molecular expression proﬁle or by their initial location in
the primordium.
We ﬁnd that single E9.5 pancreatic cells exhibit heterogeneous
contribution to organ formation, as we identify unipotent
endocrine, bipotent ducto-endocrine and multipotent clones by
lineage tracing at clonal density (Fig. 8). Among these categories,
only the unipotent endocrine-committed cells can be predicted
by single-cell molecular proﬁling at E9.5. These cells account for
50% of founder cells and encompass the already differentiated
endocrine cells and Neurog3-expressing endocrine progenitors
each accounting for about 12% of pancreatic cells at this stage
(Supplementary Fig. 7). In addition, early endocrinogenesis
encompasses other endocrine-biased cells, some of which may be
replicative, possibly expressing low levels of Neurog329. The size
of this population is estimated to about 25% of all pancreatic cells
based on both Rosa26CreER and Hnf1bCreER lineage tracing.
Although we did not identify any positive predictor for such
endocrine-biased progenitors, Ptf1a is a negative correlator based
on the rarity of unipotent endocrine clones from Ptf1aCreER-based
lineage tracing, as well as the negative correlation with known
endocrine speciﬁers from single-cell qRT-PCR (Supplementary
Fig. 3). This is in agreement with the previous observation that
early endocrine cells can form in the absence of Ptf1a33, 34. The
fact that 50% of the cells in the emerging pancreatic primordium
are biased to the endocrine lineage is surprising, since the
endocrine cells make only 1–2% of the adult pancreas26. As the
largely non-proliferative nature of endocrine-biased cells extends
the time required to generate an organ of proper size, the
generation of such a high fraction of endocrine cells at early
stages of organogenesis contradicts expectations of optimal design
theories5. These cells may thus carry important functions for the
development of the mouse pancreas, perhaps by producing
growth-stimulating components.
Despite heterogeneous and spatial differences in expression of
pancreatic progenitor-associated transcription factors within
the E9.5 bud, the bipotent ducto-endocrine and multipotent
progenitors cannot be discriminated by single-cell qRT-PCR
using our selected gene targets. Investigating more targets,
protein expression or their modiﬁcations may however uncover
subpopulations. Nevertheless, the heterogeneity in clone sizes and
differentiation is compatible with a stochastic model of cell-fate
allocation during clonal history. Comparison of several models
shows that the model that best ﬁts the data is one where cells have
a probability of differentiation and where differentiation bias
towards endocrine over acinar fates changes over time between
E9.5 and 14.5. This would imply a double molecular gate, one
controlled by the Notch pathway that controls differentiation,
and a switch controlled by an unknown molecular cue that selects
between endocrine and acinar fates. There is ample data
supporting that Notch controls the differentiation of both acinar
and endocrine lineages10, 35–38. In the model displaying optimal
ﬁt with our experimental data, the progenitors are predicted to
have a low probability of becoming endocrine at around
E11.5–E12, as supported by the progressive decrease and
subsequent reappearance of NEUROG3 cells at this time point31.
The model predicts that this corresponds to a wave of acinar
cell commitment centred at around E11.5–E12 that we can
experimentally capture (Fig. 6).
We also report spatial heterogeneity in progenitor proliferation
which may underlie the observation of progenitors that divide
only once to extreme progenies of hundreds of cells in 5 days.
Recently it was demonstrated that the progeny of dividing E10.5
pancreatic progenitors in the central area of the pancreas tends to
remain central but that this rule is not strict39. The combined
Fig. 7 The pancreatic epithelium displays regional differential proliferation explaining impacting clone size. a Schematic overview of strategy implemented
to identify spatial differences in proliferative capacities. E9.5 oral gavage and subsequent continuous administration of doxycycline (Dox) prevents
expression of H2B-GFP in Pdx1;− tTA/;tetO-H2B-GFP embryos, enabling proliferation-induced label dilution in pancreatic progenitors. b 3D MIP of whole-
mount immunostainings of dorsal pancreata at various stages following Dox administration at E9.5. Note the gradual decrease in GFP signal in SOX9+ cells
and the presence of strongly label-retaining endocrine clusters and low-retaining central progenitors, as well as the absence of label retention in the distal
epithelium and in lateral branches by E14.5 (n= 3 at E9.5 and n= 4 each at E12.5 and E14.5). Representative images were extracted from those. Scale bars,
30 µm (E9.5), 80 µm (E12.5) and 150 µm (E14.5). c Optical sections of E12.5 (top) and E14.5 (bottom) dorsal pancreata following Dox administration
at E9.5. E-CADLow endocrine clusters display strong label retention, whereas label-dilution is more pronounced in the proliferative SOX9+ progenitors.
Distal lateral branches at E14.5 display complete absence of H2B-GFP retention. Scale bars, 50 µm (E12.5) and 30 µm (E14.5). d Following E11.5 Dox
administration, the central portions of the E14.5 pancreas retains H2B-GFP signal, whereas lateral branches exhibit label dilution (n= 3 at E11.5 and n= 1
at E14.5, from which representative images were extracted). Scale bars, 70 µm (E11.5) and 150 µm (E14.5). e Kernel density estimation of SOX9+
progenitors and the density of the top 10% highest GFP-retaining SOX9+ cells. Note the central location of GFP-retaining cells. f One-dimensional
projection of SOX9+ progenitors and the top 10% of GFP-retaining cells onto a diagonal line running along the length axis of the dorsal pancreas
demonstrate enrichment of GFP-signal in distinct domains of the pancreatic epithelium. g, h 3D MIP showing the spatial distribution of clonal progeny in a
small clone in the central, proximal epithelium and a large distal clone, respectively. Scale bars, 150 µm. i Comparison of spatial distribution of smallest and
the half of largest clones from Hnf1bCreER-mediated E9.5-E14.5 clonal analysis (n= 12 clones in total)
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effect of probabilistic cell fate choices operating downstream
of spatially biased progenitor proliferation and differentiation
thus ultimately determines the contribution of progeny from
proliferating progenitors to pancreas organogenesis.
Similar to our observations, differential potency and lineage
contribution of progenitors expressing early organ markers have
recently been demonstrated during heart development40. Our
ﬁndings might facilitate the identiﬁcation of niche-derived signals
supporting in vitro generation of speciﬁc pancreatic cell types
for regenerative medicine purposes and help elucidate the
rules governing embryonic organogenesis by the concerted
spatio-temporal orchestration of clones with variable contribu-
tions to organ formation.
Methods
Mice. Mice (Mus musculus) of mixed background were housed at the University of
Copenhagen. All experiments were performed according to ethical guidelines
approved by the Danish Animal Experiments Inspectorate (Dyreforsøgstilsynet).
The following genetically modiﬁed mouse lines were used: Pdx1-tTA41,
tetO-HIST1HBJ/GFP(tetO-H2B-GFP)42, Hnf1btm(CreER) (Hnf1bCreER)17, Gt
(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J (mT/mG)24, Ptf1aCreERTM
(Ptf1aCreER)16, Tg(Hes1-EGFP)1Hri (Hes1-eGFP)43, Gt(ROSA)26Sortm1(cre/ERT2)Tyj/J
(Rosa26CreER)23. The data were collected on male and female embryos.
Whole-mount immunohistochemistry. Embryonic gut tubes or isolated pancreata
were ﬁxed in 4% paraformaldehyde (PFA) for 10–30 min on ice depending on
tissue size. After washing in PBS and dehydration in methanol (MeOH), ﬁxed
tissue was stored in 100% MeOH at −20 °C. Rehydrated samples were transferred
to PBS + 0.5% Triton X-100 (PBST). Samples were blocked overnight at 4 °C in
PBST + 1% bovine serum albumin (BSA) or in blocking solution from the
Mouse-on-Mouse (MOM) detection kit (Vector laboratories) if using mouse
primary antibodies (For details of antibodies and and concentrations use, please see
Supplementary Table 1). Primary antibodies were incubated in PBST + 1% BSA or
MOM diluent for 48 h at 4 °C. Samples were washed all day in PBST with a
minimum of ﬁve washing buffer changes before addition of secondary antibodies
and DNA staining dyes such as 4′,6-diamidino-2-phenylindole (DAPI) or DRAQ5.
Biotinylated antibodies and secondary antibodies were supplied in PBST + 1% BSA
or MOM diluent for 48 h at 4 °C followed by tissue washing and dehydration to
100% MeOH. Samples were stored at −20 °C in 100% MeOH until imaging.
Sample clearing and imaging. For imaging of whole-mount stained pancreata and
subsequent 3D reconstruction, samples were subjected to clearing, hereby reducing
light scattering. Optical clearing was performed by submerging samples in a
1:2 solution of benzyl alcohol:benzyl benzoate (BABB). Cleared samples were
subsequently mounted in glass concavity slides and submerged completely in
BABB to maintain refractive index matching and sample transparency. Cleared
samples were imaged using a Leica SP8 confocal microscope with a 20×/0.75 oil
immersion objective at 1024 × 1024 resolution. Samples were imaged in an 8-bit
format unless otherwise indicated.
In vivo clonal analysis. 4-OH tamoxifen (4-OHTm, Sigma, H6278) was
prepared as a 10 mg/mL stock solution in 10% ethanol and 90% corn oil and
subsequently diluted in vehicle solution (10% ethanol, 90% corn oil) to obtain the
desired concentration. For E9.5 to E14.5 clonal analyses, mice carrying Hnf1bCreER;
mT/mG, Ptf1aCreER;mT/mG and Rosa26CreER;mT/mG embryos received a single
intraperitoneal injection of 4-OHTm at E9.5, at a concentration of 11.5 μg/g,
57.5 μg/g and 1.35 μg/g, respectively. The dosage of 4-OHTm required to reach
labelling at clonal density was initially determined by performing dose titration
of E9.5 injections and analysis of clone density at E10.5 by whole-mount
immunostaining. The temporal accuracy of labelling was tested using the
Ptf1aCreER;mT/mG. As PTF1A expression starts at E9.5, we injected57.5 μg/g
4-OHTm at E7.5 or E8.5 and observed no labelled cell at E14.5 in 9 embryos
analysed in total (4 embryos from E7.5 injection and 5 from E8.5 injection). Using
ImarisTM software, GFP+ cells were identiﬁed in 3D reconstructed pancreata, and
the fate of cells determined by immunostaining for various pancreatic lineage
markers. For the E9.5-E10.5 short-term clonal analysis, GFP+ labelled cells were
considered to be of clonal origin if one cell was seen or if the distance between
recombined cells was less than 30 μm after the tracing period, based on the
estimates of cell migratory capacity from Kim et al.19. For the mapping of clone
position in the E10.5 bud, embryos harbouring one labelled cell or two labelled
sister cells were considered for the analysis.
Single-cell qRT-PCR. E9.5 gut tube regions spanning the pancreatic bud and
proximal duodenum were isolated from Hes1-eGFP embryos and stored in PBS on
ice until all gut regions had been collected. Embryonic mT/mG tissue was added as
a tissue spike-in to generate a bulk pellet mass preventing loss of the scarce GFP+
cell population. The pooled Hes1-eGFP gut tubes and mT/mG embryonic tissue
was dissociated in 0.05% trypsin-EDTA (Gibco) containing 200 U DNase I (Roche)
for 15 min at 37 °C with manual trituration using a p1000 pipette. Following
dissociation, PBS + 10% FCS was added to inactivate the trypsinisation, and
the single-cell suspension was centrifuged and re-suspended in PBS + 10% FCS
followed by another round of centrifugation. The single-cell suspension was
re-suspended in PBS + 10% FCS + DAPI to allow exclusion of DAPI+ dead cells.
260 single GFP+ cells were sorted into 96-well plates containing 5 μL CellsDirect
2× reaction mix (Invitrogen) and 0.05 U SUPERase-InTM RNase inhibitor
(Thermo Fischer). 96-well plates containing single cells in CellsDirect were stored
at −80 °C until ready to perform single-cell qRT-PCR reaction.
Prior to single-cell qRT-PCR, all primer pairs (Supplementary Table 2)
had been validated on E14.5 bulk pancreatic cDNA using standard qRT-PCR.
A mix containing forward and reverse primers for all 96 target genes were prepared
in TE-buffer, generating a ﬁnal concentration of 500 nM for each primer. mRNA
from single cells was next subjected to one-step reverse transcription and speciﬁc
target ampliﬁcation according to the Fluidigm protocol ‘One-Step Single-Cell Gene
Expression Using EvaGreen® SuperMix on the BioMarkTM HD system’. Upon
loading of 96 × 96 chips, a 5-fold standard series of E14.5 bulk cDNA was added to
ﬁve chip inlets, allowing identiﬁcation of speciﬁc gene product detection by
comparison of melt proﬁles of single-cell ampliﬁcations and bulk reactions.
Using Fluidigm Real-Time PCR analysis software, data from three independent
chip runs were combined, and individual reactions were passed (203)/failed (57)
according to software peak detection and melt peak temperature being in range
with bulk reactions. Expression of housekeeping genes was used as inclusion
criterion for downstream analysis of individual cells. Single-cell qRT-PCR data
were subsequently analysed using Fluidigm SINGuLARTM Analysis Toolset, while
global gene correlation tSNE-mediated dimensionality reduction was performed
using a Python-based script (code available upon request). For the analysis of
Pdx1+ pancreatic progenitors, cells were categorised as being positive for Pdx1 if
displaying CT values <20 for Pdx1.
E10.5 - 24h post label induction E11.5 - tip/trunk segregation onset E14.5 - tip/trunk segregation complete
Acinar cells
Endocrine
cells
Trunk
progenitors
Fig. 8 Proposed model of orchestration of pancreas organogenesis by heterogeneous clones. Although initially possessing the same intrinsic potency, the
spatial position of induced clones in the pancreatic bud inﬂuences expressed in vivo potency by dispersing clonal progeny to different niches. While
peripherally labelled cells (yellow outline) will be exposed to acinar-inducing cues concomitant with generation of trunk-fated progeny during branching
morphogenesis, centrally labelled cells (red outline) are less likely to experience acinar-inducing signals and thus produce ducto-endocrine bipotent clones.
Stochastic priming of centrally located progenitors towards the endocrine lineage might further generate heterogeneity in clonal contribution to the ductal
and endocrine lineage
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Model implementation. We started simulating each clone from a cell in a
progentor state and when comparing with clonal data (Figs. 1h and 4f), we only
included clones with at least one progenitor. The model thus underestimates the
number of clones fully commited to endocrine cells, but it does not affect our
results since we only look at the acinar fractions. The algorithm follows the steps
below.
First, start with cell in a progentor state. Second, draw a cell cycle length, tcc,
from a Gamma-distribution from19. To account for the unknown start of the cell
cycle for the ﬁrst cell, choose a random start between 0 and tcc. Third, after time
counter reaches tcc the cell divides and adopts one of three possible fates according
to the diagram in Fig. 5a: Progenitor probability 1 − c, acinar fate with probability c
(1 − f) and endocrine fate otherwise. Fourth, assign two new cell-cycle lengths from
the Gamma distribution. Fifth, repeat steps 3–4 for all cells.
For model 1: f= q, while for model 2: f q; tð Þ ¼ qþ 0:5 1 qð Þð1þ cosð2πtÞÞ
To estimate a probabilityprobaiblity density function (PDF) for a distribution of
discrete datapoints we use KDE. In effect it is a smoothening step, where each data
point is represented by a kernel (in our case gaussian with sigma= 6.5 for data sets
from Supplementary Fig. 7d and sigma = 0.015 for combined data set Figs. 1h and
4f, also referred to as bandwidth)44.
We ﬁnd the likelihood, L, of an observation, xi, being consistent with the model
by evaluating the PDF at xi, PDF(xi). The likelihood that all datapoints in a data set
are consistent with the model is a product of their individual likelihoods. If there
are two different data sets, their likelihoods are thus
L1 ¼
Q
i
PDF1 xið Þ; L2 ¼
Q
j
PDF2 xj
 
; and the likelkihood of both datasets
agreeing with the model is L=L1L2.
The AIC is a method for selecting among models. It does not give an absolute
estimate of how well each of the models ﬁts the data but AIC= 2k − ln(L) where
k is the number of variables and L is the maximum likelihood, i.e., corresponding
to the optimal parameter set45. The model with the lowest AICc is the preferred
model. The relative probability that an inferior model is as good as the preferred
model can be calculated by use of the equation pi= exp(AICmin −AICi).
Label retention experiments and image analysis. Pregnant mice carrying
Pdx1-tTA;tetO-H2B-GFP were subjected to oral gavage of 200 μL of 2 mg/mL
doxycycline hyclate (Dox, Sigma), 3.5% vol/vol sucrose in H2O at E9.5 or E11.5,
and subsequently this solution replaced ad libitum water supply to maintain
repression of H2B-GFP expression. Following whole-mount immunostaining,
cleared samples were imaged at 12-bit depth and subjected to 3D reconstruction
and downstream analysis in ImarisTM (Bitplane). Progenitor cells were identiﬁed
by SOX9 immunoreactivity, and the pancreatic epithelium was masked based on
SOX9 staining in order to exclude label-retaining endocrine cells from further
analysis. The xyz position of SOX9+ progenitors was obtained using the ImarisTM
spot detection algorithm on the SOX9-masked channel, additionally enabling
extraction of mean GFP immunostaining intensity signal from the volume of the
spot encompassing SOX9+ nuclei. Kernel density estimation of SOX9+ and the top
10% of GFP cells was applied to estimate the 2D distribution of these two cell
populations. For the one-dimensional analysis of GFP retaining cell distribution,
the distal-most point of the dorsal pancreatic epithelium and the centre of the
dorsal pancreatic epithelium just proximal to the turning of the ductal structure
connecting the dorsal pancreas to the ventral was used to extract the equation for
the diagonal line running between these two points along the length axis of the
dorsal pancreas. Using standard trigonometry, the xy-coordinates of SOX9+
progenitors and the xy-coordinates of the top 10% GFP-retaining SOX9+ cells
were used to project these cells onto the diagonal line and ultimately to calculate
the xy-coordinates of the intersection between the diagonal and projection line.
Finally, the distance between the intersection point and the distal landmark
was calculated, allowing kernel density estimation of SOX9+ cells and the top
10% GFP-retaining SOX9+ cells along this one-dimensional length axis.
For the analysis of spatial distribution of clones according to total clone size,
clones from Hnf1bCreER-mediated E9.5–E14.5 lineage tracing amenable to analysis
were classiﬁed as small and large so that both groups contained an equal number of
clones.
Quantiﬁcation of endocrine precursor cell ratios. Quantiﬁcation of the ratio of
endocrine precursors, namely, SOX9, NEUROG3, PAX6 and PTF1a,
progenitors and acinar precursors obtained at E9.5, E10.5, E11.5, E12.5 and E14.5
(Supplementary Fig. 7). At E9.5, cells were manually counted. At E10.5–E12.5, cell
numbers were determined using ImarisTM spot detection. For the quantiﬁcation of
putative acinar progenitors at E11.5 and E12.5, PTF1AHigh cells were quantiﬁed
based on mean intensity of nuclear PTF1A above 80 grey scale values from 8-bit
format images. This pixel intensity threshold was selected based on the intensity of
PTF1A+ cells segregated to the periphery at E11.5 and E12.5, although PTF1A+
displaying mean intensity values above the threshold are still found scattered
within the central epithelium. At E14.5, absolute cell numbers were determined
using a custom built image segmentation and analysis software.
Neighbour identiﬁcation by Voronoi-Delaunay triangulation. The xyz
coordinates of E9.5 pancreatic progenitors were obtained after manual spot
detection of SOX9+ nuclei in 3D reconstructed images of E9.5 gut tubes. The
mean ﬂuorescence intensity of the applied staining for pancreatic transcription
factors were extracted from the spot volume. Voronoi-Delaunay triangulation
was implemented using a python-based script, and a 10 μm distance threshold
was applied in order to identify nearest neighbours with biological meaning.
The coefﬁcient of variation, as well as the mean intensity of neighbours was
computed from corresponding ﬂuorescence intensities of neighbour-connected
cells, in order to visualise spatial patterns of heterogeneity and regionalisation
of transcription factor expression levels.
Code availability. Python and Python-Notebook code ﬁles, along with an
explanatory Read-me ﬁle, linked to Fig. 5 are provided as Supplementary Soft-
ware, under the GNU General Public Licence (GPL). Codes are available upon
request for label retention experiment quantiﬁcations and Voronoi-Delaunay
triangulations.
Data availability. The authors declare that all data supporting the ﬁndings of this
study are available within the article and its Supplementary Information ﬁles or
from the corresponding author upon reasonable request.
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